News Breaks |
|
|
| October 17, 2012 |
| 08:10 EDT |  | STJ | St. Jude Medical sees Q4 CRM sales $660M-$690M
Sees FY CRM sales $2.832B-$2.86B. 2012 guidance assumes that CRM market for CY12 will decline at low to mid single digit rate on a constant currency basis. Says assumes that St. Jude Medical will maintain or slightly improve its 26% -27% share of the global CRM market. Sees Q4 AF product sales $220M-$235M, sees FY sales $879M-$894M. |
|
|
News For STJ From The Last 14 Days Check below for free stories on STJ the last two weeks. |
|
|
| May 20, 2013 |
| 11:12 EDT | | STJ | St. Jude Medical to evaluate defibrilator lead related to reported death
 Subscribe for More Information |
|
| May 16, 2013 |
| 08:05 EDT | | STJ | St. Jude Medical's 3-D vessel reconstruction system approved in Europe
St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform. |
|
| May 14, 2013 |
| 08:09 EDT | | STJ | St. Jude Medical announces first patient enrolled in EnligHTN III study
Subscribe for More Information |
|
| May 9, 2013 |
| 14:01 EDT | | STJ | St. Jude says analysis demonstrates safety, reliability of Optim-insulated leads
Subscribe for More Information |
|
| 09:27 EDT |  | STJ | Leerink's medical devices analyst holds a conference call
Subscribe for More Information |
|
| May 8, 2013 |
| 08:09 EDT | | STJ | St. Jude Medical announces CE Mark approval of ICDs, CRT-Ds
Subscribe for More Information |
|
|
|
|
|
